Isorif Tablets BP 300 mg + 150 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Isorif Tablets BP 300 mg + 150 mg | Manufacturer
Product image for Isorif Tablets BP 300 mg + 150 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Isorif |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | BP |
| Product Type | Tablet |
| Category | Antitubercular drugs – Combination therapy |
| Subcategory | Combination therapy |
| Active Ingredient | Isorif |
| Strength | 300 mg + 150 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antitubercular drugs – Combination therapy |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Isorif Tablets BP 300 mg + 150 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. First-line multidrug treatment of pulmonary and extrapulmonary tuberculosis. 2. Prophylaxis and latent tuberculosis infection management in high-risk individuals. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Isorif Tablets BP 300 mg + 150 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Isorif Tablets BP 300 mg + 150 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.Quality control and assuranceRequest the approved finished-product specification for Isorif Tablets BP 300 mg + 150 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.Primary and secondary packagingThe catalogue pack for Isorif Tablets BP 300 mg + 150 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally as a single daily dose on an empty stomach (at least 30 minutes before meals or 2 hours after meals) with water. Ensure continuous daily administration under directly observed therapy protocols. | ||||||||||||||||||||||||
| Side Effects | Common: Gastrointestinal distress, anorexia, nausea, orange-red discoloration of body fluids, mild transaminase rise. Uncommon: Peripheral neuropathy, arthralgia, headache, dizziness, cutaneous flushing. Rare: Drug-induced hepatotoxicity, optic neuritis, thrombocytopenia, hemolytic anemia. | ||||||||||||||||||||||||
| Warnings and Precautions | Hepatic Function Surveillance: Baseline and monthly liver function tests are recommended; immediately discontinue if transaminases exceed 3-5 times normal. Neuropathy Prophylaxis: Co-administer pyridoxine (vitamin B6) in patients susceptible to peripheral neuritis. Adherence: Strict uninterrupted compliance is vital to prevent MDR-TB emergence. | ||||||||||||||||||||||||
| Contraindications | 1. Hypersensitivity to Isorif or related hydrazide/rifamycin antimycobacterial drugs. 2. Severe acute liver disease or preexisting drug-induced hepatitis. 3. Severe peripheral neuropathy or preexisting optic neuritis (for ethambutol). | ||||||||||||||||||||||||
| Drug Interactions | 1. Potent CYP Inducers/Substrates: Rifamycin derivatives accelerate hepatic metabolism of oral contraceptives, warfarin, and protease inhibitors. 2. Antacids: Aluminum hydroxide decreases antimycobacterial absorption; space dosing by 2 hours. 3. Hepatotoxic Drugs & Alcohol: Compounded risk of severe hepatic necrosis. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Isorif Tablets BP 300 mg + 150 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Isorif Tablets BP 300 mg + 150 mg? | The source specification is BP; confirm the required standard before contracting. |
| What quality tests are applicable for Isorif Tablets BP 300 mg + 150 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Isorif Tablets BP 300 mg + 150 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Isorif Tablets BP 300 mg + 150 mg? | Provide forecast volume, target market, strength and packaging requirements. |
Related Products
✚
Isorif Tablets BP 300 mg + 150 mg ExporterView product →
✚
Isorif Tablets BP 300 mg + 150 mg SupplierView product →
✚
Healthy Kit Tablets BP 20 mg + 1.5 g + 2.9 g ExporterView product →
✚
Healthy Kit Tablets BP 20 mg + 1.5 g + 2.9 g ManufacturerView product →
✚
Healthy Kit Tablets BP 20 mg + 1.5 g + 2.9 g SupplierView product →
✚
Rip Tablets BP 150 mg + 75 mg + 400 mg ExporterView product →
✚
Rip Tablets BP 150 mg + 75 mg + 400 mg ManufacturerView product →
✚
Rip Tablets BP 150 mg + 75 mg + 400 mg SupplierView product →
✚
Ripe Tablets BP 150 mg + 75 mg + 400 mg ExporterView product →
✚
Ripe Tablets BP 150 mg + 75 mg + 400 mg ManufacturerView product →
✚
Ripe Tablets BP 150 mg + 75 mg + 400 mg SupplierView product →
Latest Posts
✚
What are acarbose tablets used for?Read article →✚
amikacin injection product usageRead article →✚
bharat-s-leading-pharmaceutical-manufacturerRead article →✚
india's leading pharmaceutical manufacturerRead article →✚
WHO GMP certfied Hydralazine hydrochloride Tablets ManufacturerRead article →✚
WHO GMP certfied Haloperidol Tablets ManufacturerRead article →✚
WHO GMP certfied Griseofulvin Tablets ManufacturerRead article →✚
WHO GMP certfied Glyceryl Trinitrate Tablets ManufacturerRead article →